Researchers at the Francis Crick Institute and the University of Western Australia have developed a new imaging method to see where antibiotics have reached bacteria within tissues. The method could be used to help develop more effective antibiotic treatments, reducing the risk of antibiotic resistance.

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

The Stop TB Partnership released a video highlighting the work accomplished by TB REACH in 2020 in fighting TB while combating COVID-19.

The World Health Organization (WHO) Global TB Program released a newsletter highlighting the overall progress in the global TB response in 2020, emphasizing that urgent and more ambitious investments and actions are required to put the world on track to reach TB targets, especially in the context of the COVID-19 pandemic.

The Global Coalition of TB Activists (GCTA) released a newsletter highlighting the initiatives and activities carried out by the organization during the second half of 2020 in the complex context of the COVID-19 pandemic and its impact on the TB response.

In less than a year, scientists were able to develop several efficacious vaccines against COVID-19.

THOUSAND OAKS, Calif. and MELBOURNE, Australia, Dec. 22, 2020 -- Amgen (NASDAQ:AMGN) and Medicines Development for Global Health (MDGH), a non-profit biopharmaceutical company, today announced that the companies have entered into a license agreement for AMG 634, a phosphodiesterase type 4 (PDE4) inhibitor being investigated for the treatment of tuberculosis (TB) and erythema nodosum leprosum (ENL), an inflammatory cutaneous and systemic complication of leprosy. The compound is in Phase 2 development with studies led by the Aurum Institute NPC (TB study) and The Leprosy Mission Nepal (ENL study). Amgen had acquired AMG 634 (formerly CC-11050) as part of its acquisition of Otezla^® (apremilast) from Celgene in 2019. Under the terms of the agreement, MDGH will assume full responsibility for the further development and commercialization of AMG 634.

The UK All-Party Parliamentary Group on Global TB (APPG) publishes a new report entitled ‘The Future of TB and Global Health Research: Dying for A Cure II'. The full report can be accessed here.

The Union’s Tuberculosis and Migration working group has released a statement stressing that there must not be neglect of tuberculosis (TB) among migrants during the COVID-19 pandemic.

Viruses are infamous for the infectious diseases they cause in different organisms — the year 2020 has proved it for us to see. But, a virus that causes an infection in one organism could be harmless in another. The Nipah virus, for example, is harmless in bats but causes a deadly disease in humans. Likewise, there are a group of viruses called bacteriophages that infect and kill bacteria but are generally harmless in humans. Within this group of viruses are myriad individuals, each one specific to certain bacteria.